Roth Capital Upgrades Dendreon (DNDN) to Neutral

Go back to Roth Capital Upgrades Dendreon (DNDN) to Neutral

Dendreon (DNDN) Files for Chapter 11 Bankruptcy

November 10, 2014 6:48 AM EST

Dendreon Corporation (NASDAQ: DNDN) announced that it has reached agreements on the terms of a financial restructuring with certain holders of the Companys 2.875% Convertible Senior Notes due 2016 representing approximately 84% of the $620 million aggregate principal amount of the 2016 Notes. Under the terms of the agreements, the financial restructuring may take the form of a stand-alone recapitalization or a sale of the Company or its assets. The transactions under the agreements will enable continued delivery of PROVENGE® (sipuleucel-T) without disruption or impact to access for providers and appropriate patients in need of this revolutionary personalized immunotherapy... More